RHY 4.29% 6.7¢ rhythm biosciences limited

if Bescreened can manage to sell tests on the strength of a...

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    if Bescreened can manage to sell tests on the strength of a single dodgy tiny clinical trial and a few misleading investor presentations, all whilst their panel of bio markers relies on CEA, widely agreed to be unsuitable for population screening... then, actually, I'm feeling even more positive about Colostat's potential than I was before!
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
6.7¢
Change
-0.003(4.29%)
Mkt cap ! $16.65M
Open High Low Value Volume
6.5¢ 6.7¢ 6.5¢ $4.616K 70.97K

Buyers (Bids)

No. Vol. Price($)
1 38161 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.7¢ 34326 1
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.